| Q30202947 | A highly stable minimally processed plant-derived recombinant acetylcholinesterase for nerve agent detection in adverse conditions |
| Q37648773 | Antisense miR-132 blockade via the AChE-R splice variant mitigates cortical inflammation |
| Q38058374 | Blood-brain barrier dysfunction-induced inflammatory signaling in brain pathology and epileptogenesis |
| Q51973293 | Cholinergic status modulations in human volunteers under acute inflammation. |
| Q35036163 | Different sensitivities of rat skeletal muscles and brain to novel anti-cholinesterase agents, alkylammonium derivatives of 6-methyluracil (ADEMS) |
| Q37070558 | Functional Analysis and Molecular Docking studies of Medicinal Compounds for AChE and BChE in Alzheimer's Disease and Type 2 Diabetes Mellitus |
| Q33395499 | Hairy-root organ cultures for the production of human acetylcholinesterase |
| Q28485215 | Non-muscarinic therapeutic targets for acute organophosphorus poisoning |
| Q39004225 | Organophosphate-Hydrolyzing Enzymes as First-Line of Defence Against Nerve Agent-Poisoning: Perspectives and the Road Ahead |
| Q34377206 | Plant-derived human butyrylcholinesterase, but not an organophosphorous-compound hydrolyzing variant thereof, protects rodents against nerve agents |
| Q41620409 | Plant-expressed cocaine hydrolase variants of butyrylcholinesterase exhibit altered allosteric effects of cholinesterase activity and increased inhibitor sensitivity |
| Q34639611 | Reversal of succinylcholine induced apnea with an organophosphate scavenging recombinant butyrylcholinesterase |
Search more.